Intraductal carcinoma of the prostate: indicator of aggressive disease. [ 2015 - 2018 ]

Research Grant

Researchers: Prof Gail Risbridger (Principal investigator) ,  A/Pr Declan Murphy ,  Dr Renea Taylor ,  Prof Damien Bolton ,  Prof Mark Frydenberg

Brief description This proposal addresses the need to improve personalised treatment decisions for men with high risk familial prostate cancer as they have a very aggressive disease progression with a very poor clinical outcome. We will perform biological and pre-clinical studies to improve the clinical diagnosis, prognosis and treatment options for men with germline mutations in BRCA2 or BRCA1 genes who develop prostate cancer.

Funding Amount $AUD 884,377.18

Funding Scheme Project Grants

Notes Standard Project Grant